2021: the year mRNA therapeutics came of age
pharmaphorum
DECEMBER 13, 2021
It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget. The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. It’s a promise that a number of big pharma are staking on – Sanofi for one.
105 
Let's personalize your content